Q3 2023 Medical Facilities Corp Earnings Call Transcript
Excluding the divested ASCs, overall surgical case volumes increased 1%. Observation cases increased significantly by 39.5%, while inpatient cases decreased by 9.2% and outpatient cases decreased by 3.4%, while our operating expenses increased by $0.3 million to $92 million. As a percentage of revenue, they fell to 88% in the quarter from 89.8% year ago.
Consolidated salaries and benefits increased by $0.5 million or 1.6% as we experienced higher clinical and nonclinical salaries and wages due to annual salary adjustments, growth in full-time equivalent staff and market wage pressures.
Bringing anesthesia services and related billing in-house (technical difficulty) also contributed to this increase. It's important to note that these increases were mostly offset by the impact of the MFC Neuterra divestitures and our ongoing cost saving initiatives at the corporate level.
Consolidated drugs and supplies increased by $0.4 million or 1.1%, driven by changes in case mix, which included a higher proportion of orthopedic and signed
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |